Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2022 Filed Dec 19, 2022 22:20 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 491 | $109.82 | $53,923.24 |
DisclosureSEC source: 0001209191-22-061996 · doc4.xml · nonDerivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,533 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.6401 to $109.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 22:17 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 306 | $109.82 | $33,603.63 |
DisclosureSEC source: 0001209191-22-061993 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,034 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.6401 to $109.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 734 | $109.79 | $80,585.71 |
DisclosureSEC source: 0001209191-22-061969 · doc4.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,933 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.6401 to $109.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:56 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 612 | $109.79 | $67,191.36 |
DisclosureSEC source: 0001209191-22-061961 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,591 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.6401 to $109.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:20 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 469 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061996 · doc4.xml · derivative · entry 5 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 Underlying: Common Stock · 469 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On June 29, 2020, the reporting person was granted 7,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. F5 · derivative.expiration_date: On June 29, 2020, the reporting person was granted 7,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:20 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 781 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061996 · doc4.xml · derivative · entry 4 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,688 Underlying: Common Stock · 781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. F4 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:20 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 469 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061996 · doc4.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:20 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061996 · doc4.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:17 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 781 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061993 · doc4.xml · derivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,688 Underlying: Common Stock · 781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. F4 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:17 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061993 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061969 · doc4.xml · derivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 30,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. F4 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 30,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061969 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:56 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,563 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061961 · doc4.xml · derivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 1,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 25,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. F4 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 25,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on December 15, 2022. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:56 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061961 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 23:34 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 2,000 | $127.55 | $255,100.00 |
DisclosureSEC source: 0001209191-22-059492 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,792 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 11:23 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 10,684 | $123.72 | $1,321,824.48 |
DisclosureSEC source: 0001627436-22-000007 · primary_doc.xml · nonDerivative · entry 1 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,736,388 F1 · ownership.nature: Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns 100% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: These securities are held by SCP MF, PARC MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 20:07 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 83,477 | $122.18 | $10,199,219.86 |
DisclosureSEC source: 0001627436-22-000006 · primary_doc.xml · nonDerivative · entry 3 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonote Disclosed balance after: 2,747,072 F1 · ownership.nature: Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns 100% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: These securities are held by SCP MF, PARC MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 22:18 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 1,373 | $123.45 | $169,496.30 |
DisclosureSEC source: 0001209191-22-058881 · doc4.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,559 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of RSUs. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $122.80 to $123.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 22:18 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 84 | $122.55 | $10,294.60 |
DisclosureSEC source: 0001209191-22-058881 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,932 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of RSUs. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $121.7101 to $122.565, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 20:07 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 32,857 | $122.23 | $4,016,111.11 |
DisclosureSEC source: 0001627436-22-000006 · primary_doc.xml · nonDerivative · entry 2 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonote Disclosed balance after: 2,830,549 F1 · ownership.nature: Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns 100% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: These securities are held by SCP MF, PARC MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| November 24, 2022 Filed Nov 28, 2022 22:18 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058881 · doc4.xml · derivative · entry 4 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On February 24, 2020, the reporting person was granted 60,000 restricted stock units ("RSUs"), one sixteenth of which vested on November 24, 2022. F5 · derivative.expiration_date: On February 24, 2020, the reporting person was granted 60,000 restricted stock units ("RSUs"), one sixteenth of which vested on November 24, 2022. Read SEC document |
| November 24, 2022 Filed Nov 28, 2022 22:18 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058881 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2022 Filed Nov 29, 2022 20:07 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 122,842 | $122.06 | $14,994,094.52 |
DisclosureSEC source: 0001627436-22-000006 · primary_doc.xml · nonDerivative · entry 1 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,863,406 F1 · ownership.nature: Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns 100% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: These securities are held by SCP MF, PARC MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 02:25 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 92,701 | $116.51 | $10,800,593.51 |
DisclosureSEC source: 0001627436-22-000005 · primary_doc.xml · nonDerivative · entry 2 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,986,248 F3 · price: This transaction was executed with multiple brokers during the day at prices ranging from $116.25 to $118.27. The weighted-average price is reported above. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns 100% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: These securities are held by SCP MF, PARC MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 02:25 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 34,988 | $112.50 | $3,936,150.00 |
DisclosureSEC source: 0001627436-22-000005 · primary_doc.xml · nonDerivative · entry 1 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,078,949 F1 · ownership.nature: Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns 100% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: These securities are held by SCP MF, PARC MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 16:33 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 100,570 | $110.85 | $11,148,184.50 |
DisclosureSEC source: 0001627436-22-000004 · primary_doc.xml · nonDerivative · entry 2 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Control person of managed funds Disclosed balance after: 3,174,937 F2 · price: This transaction was executed with multiple brokers during the day at prices ranging from $110.52 to $111.20. The weighted-average price is reported above. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 16:33 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 56,919 | $110.10 | $6,266,781.90 |
DisclosureSEC source: 0001627436-22-000004 · primary_doc.xml · nonDerivative · entry 1 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Control person of managed funds Disclosed balance after: 3,275,507 F1 · price: This transaction was executed with multiple brokers during the day at prices ranging from $109.99 to $112.22. The weighted-average price is reported above. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 01:31 UTC |
Sylebra Capital Ltd10% owner
Gibson Daniel PatrickDirector
|
SaleCommon Stock | 64,911 | $116.33 | $7,551,096.63 |
DisclosureSEC source: 0001627436-22-000003 · primary_doc.xml · nonDerivative · entry 1 Sylebra Capital Ltd · CIK 0001627436 · 10% owner Gibson Daniel Patrick · CIK 0001745725 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Control person of managed funds Disclosed balance after: 3,332,426 F1 · price: This transaction was executed with multiple brokers during the day at prices ranging from $116.16 to $116.46. The weighted-average price is reported above. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 02, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 8 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,640 Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:16 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 252 | $111.96 | $28,213.39 |
DisclosureSEC source: 0001209191-22-055383 · doc4.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,774 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.93 to $112.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 2,000 | $115.16 | $230,320.00 |
DisclosureSEC source: 0001209191-22-055380 · doc4.xml · nonDerivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,792 F3 · kind: The sales reported by Mr. Dossett were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 629 | $112.05 | $70,480.08 |
DisclosureSEC source: 0001209191-22-055380 · doc4.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,792 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.94 to $112.085, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
OtherCommon Stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,640 F7 · kind: Distribution of Common Stock held by DFT L.L.C. to its members for no consideration. F8 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
OtherCommon Stock | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by DFT L.L.C Disclosed balance after: 572,494 F7 · kind: Distribution of Common Stock held by DFT L.L.C. to its members for no consideration. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 401 | $115.50 | $46,313.98 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,307 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $114.97 to $115.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,543 | $114.34 | $176,426.16 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,708 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $113.93 to $114.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,956 | $113.28 | $221,583.50 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,251 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $112.90 to $113.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 109 | $112.58 | $12,271.50 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,207 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.90 to $112.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 22:06 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 991 | $111.34 | $110,342.40 |
DisclosureSEC source: 0001209191-22-055374 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,316 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $110.83 to $111.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 31, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,736 | $117.66 | $204,255.16 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 9 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,307 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F10 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $117.34 to $117.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 31, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 2,664 | $116.83 | $311,222.60 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 8 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,043 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F9 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $116.32 to $117.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 31, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 600 | $115.62 | $69,369.00 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,707 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F8 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $115.25 to $116.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 22:16 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055383 · doc4.xml · derivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On July 31, 2019, the reporting person was granted 10,000 restricted stock units ("RSUs"). One-sixteenth of these RSUs vested on October 31 2022. F4 · derivative.expiration_date: On July 31, 2019, the reporting person was granted 10,000 restricted stock units ("RSUs"). One-sixteenth of these RSUs vested on October 31 2022. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 22:16 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055383 · doc4.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,562 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055380 · doc4.xml · derivative · entry 4 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,688 Underlying: Common Stock · 1,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On July 31, 2019, the reporting person was granted 25,000 RSUs. One-sixteenth of these RSUs vested on October 31, 2022. F5 · derivative.expiration_date: On July 31, 2019, the reporting person was granted 25,000 RSUs. One-sixteenth of these RSUs vested on October 31, 2022. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 22:12 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionCommon Stock | 1,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055380 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 700 | $112.96 | $79,074.66 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,307 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $112.79 to $113.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 311 | $111.75 | $34,755.15 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,007 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.72 to $111.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 2,188 | $111.00 | $242,869.53 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,318 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $110.60 to $111.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,227 | $110.01 | $134,982.64 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,506 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.58 to $110.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.